Iron Deficiency Anemia Treatment Market Outlook: Growth and Forecast Highlights 2030
Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company
How much is the Iron Deficiency Anemia Treatment Market valued at in 2026, and what valuation is forecast for 2030?
The iron deficiency anemia treatment market size has seen rapid growth in recent years. It is anticipated to increase from $8.83 billion in 2025 to $9.98 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 13.0%. This historical growth can be attributed to the rising prevalence of iron deficiency disorders, an increase in the diagnosis of anemia in chronic diseases, the expansion of hospital-based treatment protocols, the availability of oral iron supplements, and growing awareness regarding anemia management.
The iron deficiency anemia treatment market is projected to experience substantial growth over the next few years. It is expected to expand to $16.17 billion by 2030, achieving a compound annual growth rate (CAGR) of 12.8%. This growth during the forecast period is driven by factors such as the increasing susceptibility of the geriatric population, a rising demand for rapid iron repletion therapies, the expanding use of injectable iron, a growing emphasis on patient-centric treatment models, and advancements in iron formulation technologies. Significant trends in the forecast period include the increasing adoption of intravenous iron therapies, a rise in the use of high-bioavailability iron formulations, a growing focus on personalized anemia treatment approaches, the expansion of outpatient and home-based iron therapy, and improvements in patient monitoring and compliance tools.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24266&type=smp
What Drivers Are Influencing The Growth Of The Iron Deficiency Anemia Treatment Market?
The projected rise in chronic kidney disease is anticipated to boost the expansion of the iron deficiency anemia treatment market in the coming years. Chronic kidney disease (CKD) involves the progressive deterioration of kidney function over an extended period. This escalation in chronic kidney disease (CKD) can be attributed to the growing prevalence of diabetes, given that sustained elevated blood sugar levels harm the renal blood vessels, thus hindering their waste-filtering capacity. Treatment for iron deficiency anemia aids individuals with chronic kidney disease (CKD) by enhancing oxygen distribution to tissues, alleviating tiredness, and elevating their overall quality of life. Furthermore, it may contribute to better kidney function by managing the anemia frequently stemming from diminished erythropoietin synthesis in CKD. For example, a report released by AstraZeneca, a UK-based pharmaceutical firm, in April 2024, forecasts that by 2032, as much as 16.5% of the population across eight countries, specifically the United States, Brazil, the United Kingdom, Spain, Germany, the Netherlands, China, and Australia, will be impacted by chronic kidney disease (CKD), alongside a substantial rise of up to 59.3% in advanced-stage diagnoses. Consequently, the growing incidence of chronic kidney disease is propelling the expansion of the iron deficiency anemia treatment market.
How Is The Iron Deficiency Anemia Treatment Market Organized Into Various Segments?
The iron deficiency anemia treatment market covered in this report is segmented –
1) By Treatment Type: Medications, Blood Transfusions, Other Treatment Types
2) By Drug Type: Ferrous Sulfate, Iron Carbohydrates, Other Drug Types
3) By Therapy Areas: Inflammatory Bowel Disease, Oncology, Other Therapy Areas
4) By Route Of Administration: Oral, Injectable
5) By End User: Hospitals, Clinics, Home Care Settings, Pharmacies
Subsegments:
1) By Medications: Oral Iron Supplements, Intravenous Iron Therapy, Iron-Based Injections, Erythropoiesis-Stimulating Agents
2) By Blood Transfusions: Packed Red Blood Cells Transfusion, Whole Blood Transfusion
3) By Other Treatment Types: Dietary Modifications, Iron Infusion Therapy, Long-Term Maintenance Iron Therapy
What Upcoming Trends Are Likely To Define The Future Path Of The Iron Deficiency Anemia Treatment Market?
Leading companies in the iron deficiency anemia treatment market are concentrating on developing advanced solutions, such as iron injections, to boost treatment effectiveness, safety, and patient convenience. An iron injection refers to a novel or significantly improved injectable iron therapy that represents a major step forward in managing iron deficiency or iron deficiency anemia. For example, in March 2024, Cadila Pharmaceuticals, an India-based pharmaceutical company, launched Redshot FCM, an intravenous iron therapy employing ferric carboxymaltose for the treatment of iron deficiency anemia (IDA). It offers distinct advantages, including an advanced ferric carboxymaltose formulation for rapid iron replenishment, minimal anaphylaxis risk, high-dose single-infusion administration for swift correction, and applicability for pediatric patients (1+ years) alongside adults. It accelerates hemoglobin recovery and targets vulnerable groups, such as pregnant women and cancer patients, with superior tolerability.
Who Are The Major Companies Operating In The Iron Deficiency Anemia Treatment Market?
Major companies operating in the iron deficiency anemia treatment market are Sanofi SA, Fresenius SE & Co. KGaA, Amgen Inc., Teva Pharmaceutical Industries Ltd., Sandoz Group AG, Daiichi Sankyo Company Limited, Lupin Limited, Zydus Lifesciences Limited, Alkem Laboratories Ltd., Pharmascience Inc., American Regent Inc., PharmaNutra S.p.A., Rockwell Medical Inc., Keryx Biopharmaceuticals Inc., Pharmacosmos A/S, AdvaCare Pharma USA LLC, Apotex Inc., Shield Therapeutics plc, CSL Vifor AG, Abbott Laboratories, Bayer AG, Pfizer Inc., Cipla Limited, Dr. Reddy’s Laboratories Ltd.
Access The Complete Report For Deeper Market Insights:
Which Global Regions Are Shaping The Competitive Landscape Of The Iron Deficiency Anemia Treatment Market?
North America was the largest region in the iron deficiency anemia treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the iron deficiency anemia treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Iron Deficiency Anemia Treatment Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=24266&type=smp
Browse Through More Reports Similar to the Global Iron Deficiency Anemia Treatment Market 2026, By The Business Research Company
Hemochromatosis Iron Overload Disease Treatment Global Market Report 2026
Anemia And Other Blood Disorder Drugs Global Market Report 2026
Chemotherapy Induced Anemia Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/chemotherapy-induced-anemia-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
